<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01509027</url>
  </required_header>
  <id_info>
    <org_study_id>B322201112895</org_study_id>
    <nct_id>NCT01509027</nct_id>
  </id_info>
  <brief_title>Study of the Compliance With Phosphorus Restricted Diet and Phosphate Binder Therapy in Hemodialysis Patients</brief_title>
  <official_title>A Randomized Controlled Trial to Evaluate the Impact of Education on the Knowledge About and Compliance With a Phosphorus Restricted Diet and Phosphate Binder Therapy in Maintenance Dialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hyperphosphatemia is a common and severe complication in chronic kidney disease patients
      treated with hemodialysis. A phosphate restricted diet and oral phosphate binders are the
      cornerstones in the prevention and treatment of this complication. However, noncompliance is
      an prevalent problem resulting in poorly controled hyperphosphatemia in a substantial
      proportion of hemodialysis patients. The present study aims at identifying risk factors for
      non compliance and also test the hypothesis that compliance can be improved by education
      patients on the consequences of hyperphosphatemia and the importance of diet and phosphate
      binder therapy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">June 2012</completion_date>
  <primary_completion_date type="Anticipated">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>compliance</measure>
    <time_frame>baseline and after intervention</time_frame>
    <description>impact of education (by DVD and interview with dietician)on compliance with phosphorus restricted diet and phosphate binder therapy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>serum phosphate levels</measure>
    <time_frame>baseline and after intervention</time_frame>
    <description>impact of education (by DVD and interview with dietician) on serum phosphate levels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>risk factors of noncompliance</measure>
    <time_frame>baseline</time_frame>
    <description>identification of risk factors for non compliance with emphasis on cognitive function and depression</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>Education by DVD and dietician</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Information on detrimental conseqences of hyperphosphatemia is presented on DVD and individual dietary counseling is given by dieticican</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Education by unpersonalised DVD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Information on detrimental consequences of hyperphosphatemia is presented on DVD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>standard care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>education by DVD</intervention_name>
    <description>Information on detrimental conseqences of hyperphosphatemia is presented on DVD</description>
    <arm_group_label>Education by unpersonalised DVD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard care</intervention_name>
    <description>standard care</description>
    <arm_group_label>Standard Care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Education by DVD and dietician</intervention_name>
    <description>Information on detrimental conseqences of hyperphosphatemia is presented on DVD and individual dietary counseling is given by dieticican</description>
    <arm_group_label>Education by DVD and dietician</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  prevalent (&gt;3months) hemodialysis patients

          -  aged &gt; 18 years

          -  informed consent

        Exclusion Criteria:

          -  decreased consciousness

          -  unstable

          -  medical contraindication for phosphorus restricted diet or phsophate binder therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pieter Evenepoel, MD</last_name>
    <phone>003216344580</phone>
    <email>pieter.evenepoel@uz.kuleuven.ac.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospitals Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Pieter Evenepoel</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fabienne Dobbels</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 9, 2012</study_first_submitted>
  <study_first_submitted_qc>January 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2012</study_first_posted>
  <last_update_submitted>May 29, 2012</last_update_submitted>
  <last_update_submitted_qc>May 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hemodialysis</keyword>
  <keyword>hyperphoshatemia</keyword>
  <keyword>compliance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

